Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy
This study aims to look at a comparison of liquid biopsy (blood sample) analysis compared with tissue biopsy in patients with advanced lung cancer
Checked against the public recordLast updated May 16, 2019 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Inivata
- Interventions being studied
- Not specified
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Written, signed and dated informed consent * Male \& female patients aged 18 years and over diagnosed with stage IIIb/IV non-squamous NSCLC. * Patients intended to initiate first-line treatment (Arms A and B) * Patients who plan to have or have had a recent tumor tissue biopsy taken as part of their standard of care (Arm A) * Patient must understand and be able, willing and likely to fully comply with all study procedures and restrictions. Exclusion Criteria: * Patients who have received any approved or experimental cancer therapy since their most recent NSCLC tissue biopsy * Any history of metastatic cancer. * Previous malignancy in the last 2 years (except basal cell carcinoma of the skin or pre-invasive carcinoma of the cervix). * Patient with a severe acute or chronic medical or psychiatric condition or laboratory abnormality
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Mercy Hospital Cancer Center/Clinical ResearchFort Smith, Arkansas
- Mercy Cancer CenterJoplin, Missouri
- Mercy ClinicSpringfield, Missouri
- Mercy Clinic Oncology & HematologyOklahoma City, Oklahoma
- Lehigh Valley Health NetworksAllentown, Pennsylvania
- Gibbs Cancer Center & Research InstituteSpartanburg, South Carolina
Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 16, 2019. Always confirm current availability with the study team.